For the IL-10 -592C > A polymorphism, ten studies consisting of 3,149 cases and 2,237 controls were pooled in the meta-analysis to assess whether this IL-10 -592C > A polymorphism was associated with cervical cancer risk. The gene discussed is IL10; the disease is cervical carcinoma.